The authors remarked that the results called for further education on MG symptoms for physicians outside the neurology setting. Advanced age and increased time between symptom onset appear to ...

Relative survival increased from 64% to 66%, overall survival from 54% to 55%, and lymphoma-specific survival from 64% to 66%. The advent of chimeric antigen receptor T-cell (CAR-T) therapy for ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

(Getty Images) Generalized pustular psoriasis is the most serious form of psoriasis, with more than half of all patients with the condition needing hospitalization. About half of all people with GPP ...

My recent liver biopsy was a case study of Murphy’s Law in action. And as I share the details of my saga, I’m mindful that my experience is the exception, not the rule. I do not want to discourage ...

Patients with CLL and a CSHA CFS score greater than 3 had significantly higher rates of treatment interruption due to adverse effects. The CSHA Clinical Frailty Scale (CFS) is a valuable tool for ...

Heather Landau, MD, is an oncologist-hematologist from Sloan Kettering Memorial Cancer Center in New York City, Larry Luxner, senior correspondent for Rare Disease Advisor, interviews ...

EGPA diagnosis and treatment consume significant healthcare resources, both in public and private settings. Eosinophilic granulomatosis with polyangiitis (EGPA)—a form of antineutrophil cytoplasmic ...

Yiannis Papazoglou is one of only 40 people in the world with a mutation of the IRF2BPL gene. Foundation Aims to Help Patients With Rare Diseases—Even Before They’re Recognized The Undiagnosed ...

Sangeetha Venugopal, MD, is assistant professor of clinical medicine at the University of Miami Sylvester Comprehensive Cancer Center. Larry Luxner, senior correspondent for Rare Disease Advisor, ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival. Chimeric antigen receptor-T (CAR-T) cell therapy followed by allogeneic ...

In organ donation from a donor with hemophilia, it is possible to not pass the disease onto the organ recipient. A letter to the editor of Haemophilia demonstrates the safety and feasibility of organ ...